When your bones are at risk, BILPREVDA has your back

Bone-targeting medicines can be expensive.

XGEVA (denosumab) is covered by Medicare, but it can still be costly.

The wholesale acquisition cost (WAC) for BILPREVDA is ~51% less expensive than XGEVA*

Cost and coverage for BILPREVDA is dependent on the terms and conditions of your individual insurance benefits, including any applicable deductible, co-insurance, or co-payment.

Computer-generated X-ray depiction of spine represents one
of the common sites of bone metastases.

Hero Image
BILPREVDA
XGEVA

Meets strict FDA standards for approval

3 approved uses

Highly similar safety and effectiveness

Helps protect your bones during cancer care

1 dose every 4 weeks

Meet BILPREVDA

BILPREVDA is highly similar to XGEVA

BILPREVDA is a prescription medicine used for:

Prevention of fracture, spinal cord compression, or the need for radiation or surgery to bone in patients with multiple myeloma and in patients with bone metastases from solid tumors

Treatment of adults and skeletally mature adolescents with giant cell tumor of the bone when surgery isn't an option

Treatment of high calcium levels in the blood caused by cancer when other treatments haven't worked

Biosimilars work the same way as the ORIGINAL BIOLOGIC,
at a potentially lower cost

Biosimilars like BILPREVDA can provide patients with more treatment OPTIONs

A biosimilar is an FDA-approved medicine that is highly similar to the original biologic medicine it is based on. Biologic medicines are complex. Biosimilars are not exact copies, but they go through a strict FDA approval process to make sure they are just as safe and effective as the original biologic. A biosimilar works the same way in the body as the original biologic. Biosimilars may also be available at a lower cost than the original biologics.

Cost and coverage for specific biosimilars are dependent on the terms and conditions of your individual insurance benefits, including any applicable deductible, co-insurance, or co-payment.

A biosimilar works in your body in the same way as the biologic it's based on, offering the same treatment benefits and potential side effects

BILPREVDA is brought to you by Organon Biosimilars

We are an experienced biosimilars company with:

8+

years dedicated to biosimilars in the US

6

biosimilars approved in the US and still counting

5 therapeutic areas treated:

Icon 0
Cancer care
Icon 1
Gut conditions
Icon 2
Skin conditions
Icon 3
Joint and autoimmune conditions
Icon 4
Bone health

We are committed to creating a sustainable health care future through THE development of accessible and effective treatment options for patients

Learn how BILPREVDA is administered and things to keep in mind during treatment

See what to expect

Computer-generated X-ray depiction of humerus represents one
of the common sites of bone metastases.

Hero Image